Parkinson’s diseaseoropharyngeal dysphagia
… oropharyngeal dysphagia (swallowing disorder) interventions in Parkinson’s disease by agreeing core outcomes and definitions, outcome measurement …
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 61–120 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Gastric Cancer96T2D95Acute Coronary Syndrome93Autism90Cervical Cancer89Interstitial Lung Disease89Frailty86Ischaemic Heart Disease86AIS83Glaucoma82Syphilis82Osteoporosis82Pulmonary Hypertension80Interstitial Lung Disease (ILD)79ILD78MASLD77SARS-CoV-277Intracranial Aneurysms76CArdiovascular diseases76Liver Disease74Pancreatic Cancer74Pneumonia74Obstructive Sleep Apnoea73PD70Post-traumatic stress disorder70Pregnancy69Cystic Fibrosis68Autism Spectrum Disorder68Anaemia67Osteoarthritis66UC66Ischaemic stroke66AD65OSA65Ovarian Cancer65ADHD62Malaria62AF62CSDH61Coronary heart disease59Non-communicable Diseases59Ischemic Stroke58HFpEF57CHD57Coeliac Disease57Hypertrophic Cardiomyopathy57Chronic Pain56Traumatic Brain Injury56Irritable Bowel Syndrome56PWH55SSc-ILD55Sarcoidosis55Psoriatic Arthritis54Glioblastoma53Chronic Liver Disease53Pre-eclampsia51Migraine51Neisseria gonorrhoeae51Bronchiectasis50STEMI50
Articles mentioning diseases
23,712 articles · page 205 of 1976chronic exertional compartment syndromeant-CECSCECSconservative treatmentNCT05720182
…nd is a novel non-invasive technique for detecting leg anterior chronic exertional compartment syndrome with promising diagnostic accuracy, particularly in males.Trial…
Lennox–Gastaut syndromeDravet syndromeLGSDSFenfluraminecannabidiol
…Background and Importance Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS) are severe developmental and epileptic encephalopathies w…
DRPsdiureticsWorld-Health-Organisation-Uppsala-Monitoring-Centreantithrombotic agentspsycholepticspsychoanalepticsclinical pharmaceutical interventions
…for-Medication-Error-Reporting-and-Prevention-index (NCC-MERP). DRPs that potentially caused the hospitalisation were classified acc…
HER2-positive metastatic breast cancermetastatic breast cancerHER2-low metastatic breast cancerHER2-low diseaseunresectable or metastatic breast cancerHER2-low unresectable or metastatic breast cancerHER2-positive unresectable or metastatic breast cancerHER2-positive diseaseT-DXdTrastuzumab deruxtecan
…n (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-positive metastatic breast cancer and, more recently, in HER2-low disease. However, real-world da…
98.7%
non-small-cell lung cancerurothelial bladder cancerrenal cancermelanomaoesophageal cancergastric cancerHodgkin’s lymphomahead and neck cancerNivolumab
…ageal cancer, 10 with gastric cancer, 39 with melanoma, 45 with non-small-cell lung cancer, 41 with renal cancer, seven with urothelial bladder cancer, an…
sepsisantibiotic therapytertiary hospitalantimicrobial therapy
…ented in Madrid to standardise early detection and treatment of sepsis.Aim and Objectives Primary objective: to analyse the percentage…
Chronic kidney diseasetype 2 diabeteshypertensionmetforminclinical alert programallopurinol
…Background and Importance Chronic kidney disease is a major health problem. When chronic kidney disease progress…
Ulcerative colitisIBDCrohn’s diseaseinflammatory bowel diseaseUCCDustekinumabinfliximabadalimumabADA+1 more
… and ustekinumab (UST) in patients with Crohn’s disease (CD) or Ulcerative colitis (UC), and to assess the acceptance of the pharmaceutical recomm…
diabetic neuropathychronic neuropathic and post-traumatic paincervicobrachialgiapost-herpetic neuralgiatrigeminal and facial neuralgiaback painintractable headachespre-sacral painpost-mastectomy painshoulder pain+1 more
…neuralgia, trigeminal and facial neuralgia, cervicobrachialgia, diabetic neuropathy, and shoulder pain–the BioWave system produced a mean pain redu…
transthyretin amyloidosistertiary hospitalclinical trials
…cially in diseases with high pharmaceutical expenditure such as transthyretin amyloidosis.Aim and Objectives The aim of this study was to quantify the av…
ARASENSnmCRPCmHSPCARAMISmetastatic hormone-sensitive prostate cancernon-metastatic castration-resistant prostate cancerDarolutamide
…AMIS) and metastatic hormone-sensitive prostate cancer (mHSPC) (ARASENS). Darolutamide was commercialised in 2020.Aim and Objectives To…